NEW YORK (GenomeWeb News) – Danaher's pending $6.8 billion purchase of Beckman Coulter has cleared the last regulatory hurdle, the Washington-based conglomerate announced after the close of the market Thursday.
The European Commission approved the deal, paving the way for the acquisition to close. Danaher's tender offer to acquire all outstanding shares of Beckman Coulter stock at $83.50 per share is scheduled to expire at 5 p.m. EDT, June 24. It reiterated that the deal is expected to be completed by the end of the month. The US Federal Trade Commission cleared the purchase in March.
Earlier this week, Danaher announced a public offering at $51.75 per share to raise as much as $965.3 million in net proceeds if underwriters on the offering exercise their over-allotment option in full. Net proceeds will be used to pay a portion of the acquisition. Proceeds also may be used for general corporate purposes, if there are any remaining from the offering or if the Beckman deal fails to close.